About Pernix Therapeutics Holdings, Inc.

Develops specialty pharmaceutical products

At the moment the company generates 128M USD in revenues.

On its last earning announcement, the company reported a loss of -6.45$ per share.

The book value per share is -14.72$

Pernix Therapeutics Holdings, Inc. website

Create a solid portfolio with PTX

Add PTX to your portfolio and optimize it!


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
128M 68.80% -30M -23.40% -76M -6.45 - - 12M -14.72 -22M - -22M